PETER DUYSHART

ARNOLD & PORTER KAYE SCHOLER LLP · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

In the field

2 yrs

registered since 2024

Clients

last 3 years

Filings

8 agencies contacted

Activity

filings by quarter

Works on

Health Issues 26 Medicare/Medicaid 25 Taxation/Internal Revenue Code 6 Manufacturing 6 Budget/Appropriations 6 Pharmacy 5 Energy/Nuclear 5 Copyright/Patent/Trademark 2 Tariff (miscellaneous tariff bills) 1 Labor Issues/Antitrust/Workplace 1

Background

Career

ARNOLD & PORTER KAYE SCHOLER LLP

Washington, DC

2024 - present

Government experience

Program Support Student Trainee

Secretarial Internship Program, U.S. DOT

2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015

Disclosed on LD-2 filings

Specific issues

Issues related to health care accreditation, Medicare Advantage plans -- including Medicare Advantage Special Needs Plans (SNP) reviews -- telehealth, and mental health parity. Issues related to pharmacy benefit management services and specialty pharmacies, including accreditations of both, and the Pharmacists Fight Back Act (H.R. 9096, 118th Congress).

Medicare/Medicaid · 2025 Q1

Issues related to health care accreditation, telehealth, mental health parity, and Medicare Advantage plans. Issues related to pharmacy benefit management services and specialty pharmacies, including accreditations of both, and the Pharmacists Fight Back Act (H.R. 9096, 118th Congress).

Health Issues · 2025 Q1

Issues related to telehealth accreditation, including congressional encouragement of HHS and HRSA to utilize telehealth accreditation to ensure high quality care for patients.

Budget/Appropriations · 2025 Q1

Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2023 (H.R. 4818 / S. 2407, 118th Congress).

Medicare/Medicaid · 2025 Q1

Issues related to pharmacy benefit managers (PBMs) and the 340B Program.

Pharmacy · 2025 Q1

Issues related to pharmacy benefit managers (PBMs) and the 340B program. Issues related to the clinical and overall benefit of anti-obesity medications. Issues related to insulin pricing/affordability.

Health Issues · 2025 Q1